These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 12220851)

  • 1. Human Sir2 and the 'silencing' of p53 activity.
    Smith J
    Trends Cell Biol; 2002 Sep; 12(9):404-6. PubMed ID: 12220851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.
    Bitterman KJ; Anderson RM; Cohen HY; Latorre-Esteves M; Sinclair DA
    J Biol Chem; 2002 Nov; 277(47):45099-107. PubMed ID: 12297502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.
    Langley E; Pearson M; Faretta M; Bauer UM; Frye RA; Minucci S; Pelicci PG; Kouzarides T
    EMBO J; 2002 May; 21(10):2383-96. PubMed ID: 12006491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIR2-induced inviability is suppressed by histone H4 overexpression.
    Matecic M; Stuart S; Holmes SG
    Genetics; 2002 Oct; 162(2):973-6. PubMed ID: 12399404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
    Howitz KT; Bitterman KJ; Cohen HY; Lamming DW; Lavu S; Wood JG; Zipkin RE; Chung P; Kisielewski A; Zhang LL; Scherer B; Sinclair DA
    Nature; 2003 Sep; 425(6954):191-6. PubMed ID: 12939617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
    Imai S; Armstrong CM; Kaeberlein M; Guarente L
    Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition.
    Sauve AA; Moir RD; Schramm VL; Willis IM
    Mol Cell; 2005 Feb; 17(4):595-601. PubMed ID: 15721262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation.
    Liou GG; Tanny JC; Kruger RG; Walz T; Moazed D
    Cell; 2005 May; 121(4):515-527. PubMed ID: 15907466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sir2 family of protein deacetylases.
    Blander G; Guarente L
    Annu Rev Biochem; 2004; 73():417-35. PubMed ID: 15189148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budding yeast silencing complexes and regulation of Sir2 activity by protein-protein interactions.
    Tanny JC; Kirkpatrick DS; Gerber SA; Gygi SP; Moazed D
    Mol Cell Biol; 2004 Aug; 24(16):6931-46. PubMed ID: 15282295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bypassing Sir2 and O-acetyl-ADP-ribose in transcriptional silencing.
    Chou CC; Li YC; Gartenberg MR
    Mol Cell; 2008 Sep; 31(5):650-9. PubMed ID: 18775325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique class of conditional sir2 mutants displays distinct silencing defects in Saccharomyces cerevisiae.
    Garcia SN; Pillus L
    Genetics; 2002 Oct; 162(2):721-36. PubMed ID: 12399383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic activities of Sir2 and chromatin silencing.
    Moazed D
    Curr Opin Cell Biol; 2001 Apr; 13(2):232-8. PubMed ID: 11248558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.
    Vaziri H; Dessain SK; Ng Eaton E; Imai SI; Frye RA; Pandita TK; Guarente L; Weinberg RA
    Cell; 2001 Oct; 107(2):149-59. PubMed ID: 11672523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIR2 modifies histone H4-K16 acetylation and affects superhelicity in the ARS region of plasmid chromatin in Saccharomyces cerevisiae.
    Chiani F; Di Felice F; Camilloni G
    Nucleic Acids Res; 2006; 34(19):5426-37. PubMed ID: 17012273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A yeast sir2 mutant temperature sensitive for silencing.
    Wang CL; Landry J; Sternglanz R
    Genetics; 2008 Dec; 180(4):1955-62. PubMed ID: 18845844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.